Dergiler / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 5

Cognitive impairment one year after ischemic stroke: predictorsand dynamics of significant determinants

Sayfa
1366–1373
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: The level of inflammatory markers could be considered as an additional criterion of long-term cognitive impairment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Evidence suggests that the risk for dementia increases after stroke.
📊
Temel Bulgular & Veri:This study investigated the dynamics of the neurological and cognitive status of patients with no baseline dementia over a 1-year period after ischemic stroke.
💡
Sonuç & Katkı:Conclusion: The level of inflammatory markers could be considered as an additional criterion of long-term cognitive impairment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Evidence suggests that the risk for dementia increases after stroke. This study investigated the dynamics of the neurological and cognitive status of patients with no baseline dementia over a 1-year period after ischemic stroke. Materials and methods: We examined 47 ischemic stroke patients admitted within 48 h of ictus. Their neurological and cognitive statuses, blood biochemical parameters, and microalbuminuria levels were prospectively evaluated over a 1-year period post-stroke. Results: A more severe neurological deficit was found in the cognitively impaired patients (P = 0.003). The NIHSS score over a 1-year follow-up period improved only in patients with normal cognition (P = 0.000). Time-varying dynamics of the MMSE score were observed in both patient groups (P = 0.000). Age (Р = 0.000), education (Р = 0.004), sex (Р = 0.041), history of diabetes (Р = 0.045), and serum high sensitive C-reactive protein (hs-CRP) on admission (Р = 0.003) were significant determinants of cognitive decline 1 year after a stroke. The albumin-to-creatinine ratio was high during the whole follow-up period in the cognitively impaired group after adjusting for sex and age (P = 0.010). Binary logistic regression showed that hs-CRP (Р = 0.013) and age (Р = 0.010) were independent predictors of patients cognitive status 1 year after stroke. Conclusion: The level of inflammatory markers could be considered as an additional criterion of long-term cognitive impairment.

🔖

Bu Makaleye Atıf Yap

DANOVSKA, M. P., ALEXANDROVA, M. L. (2022). Cognitive impairment one year after ischemic stroke: predictorsand dynamics of significant determinants. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 5, 1366–1373. https://ajindex.com/articles/610695

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Stephens S, Kenny RA, Rowan E, Allan L, Kalaria RN, Bradbury M, Ballard CG. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int J Geriatr Psych 2004; 19: 1053-1057
  2. Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, Tangalos EG, Ivnik RJ, Petersen RC. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol-Chicago 2009; 66: 614- 619
  3. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke. The Framingham study. Stroke 2004; 35: 1264-1269
  4. Desmond DW, Moroney JT, Sano M, Stern Y. Incidence of dementia after ischemic stroke. Results of a longitudinal study. Stroke 2002; 33: 2254-2260
  5. Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, de Haan EH, Kappelle LJ. Cognitive disorders in acute stroke: prevalence and clinical determinants. Cerebrovasc Dis 2007; 23: 408-416
  6. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005; 4: 371-380
  7. Rothenburg LS, Herrmann N, Swardfager W, Black SE, Tennen G, Kiss A, Gladstone DJ, Ween J, Snaiderman A, Lanctôt KL. The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psych Neur 2010; 23: 199-205
  8. Hamilton M. A rating scale for depression. J Neurol Neurosur Ps 1960; 23: 56-62
  9. Dominici R, Luraschi P, Franzini C. Measurement of C-reactive protein: two high sensitivity methods compared. J Clin Lab Anal 2004; 18: 280-284
  10. Johns KW, Robinson CE, Wilson IM, Billington EO, Bondy GP, Tildesley HD. Does the albumin:creatinine ratio lack clinical utility in predicting microalbuminuria? British Columbia Medical Journal 2006; 48: 399-403
  11. Serrano S, Domingo J, Rodríguez-Garcia E, Castro MD, del Ser T. Frequency of cognitive impairment without dementia in patients with stroke. A two-year follow-up study. Stroke 2007; 38: 105-110
  12. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007; 184: 53-68
  13. Jaillard A, Naegele B, Trabucco-Miguel S, LeBas JF, Hommel M. Hidden dysfunctioning in subacute stroke. Stroke 2009; 40: 2473-279
  14. Saxena SK. Prevalence and correlates of cognitive impairment in stroke patients in a rehabilitation setting. International Journal of Psychosocial Rehabilitation 2006; 10: 37-47
  15. Whall